INS and neurodegenerative disease: As a whole, insulin signaling appears to be related to a decline in domains that are typically affected relatively early in neurodegenerative diseases such as AD (episodic memory [26], working memory [27], and visuospatial abilities [28]) and in cerebrovascular disease (perceptual speed [29]), consistent with our prior publications [30].